These data indicate that deletion of Foxo transcription factors in CD4+ T cells may improve hepatic steatosis by decreasing fats stored in adipose tissues, not by decreasing hepatic de novo lipogenesis. The gene discussed is CD4; the disease is Hepatic steatosis.